Publications by authors named "Susanne Hartz"

Claim this Profile
E
Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis.
Axel Dignass, Claire Ainsworth, Susanne Hartz, Niels Dunnewind, Isabel Redondo

Adv Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Bowel Urgency in Patients With Ulcerative Colitis and Crohn's Disease: A Real-World Global Study.
Raja Atreya, Isabel Redondo, Petra Streit, Marijana Protic, Susanne Hartz

Crohns Colitis 360· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn's Disease in Italy.
Melania Dovizio, Susanne Hartz, Carlotta Buzzoni, Isabel Redondo, Marijana Nedeljkovic Protic

Adv Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical profiles and outcomes in patients with inflammatory bowel disease receiving standard and escalated doses of targeted therapies: findings from a global real-world study.
Axel Dignass, Isabel Redondo, Petra Streit, Susanne Hartz, Gamze Gurses

Curr Med Res Opin· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical profiles and outcomes in patients with ulcerative colitis receiving standard and higher-than-standard doses of vedolizumab: findings from a real-world study in Europe.
Javier P Gisbert, Petra Streit, Isabel Redondo, Susanne Hartz, Hannah Knight

Curr Med Res Opin· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK.
Bernd Schweikert, Chiara Malmberg, Örjan Åkerborg, Gayathri Kumar, Debby Nott, Susanne Hartz

Pharmacoecon Open· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain.
Bernd Schweikert, Chiara Malmberg, Mercedes Núñez, Tatiana Dilla, Christophe Sapin, Susanne Hartz

BMJ Open· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis.
Adeline Ruyssen-Witrand, Richard Perry, Clare Watkins, George Braileanu, Gayathri Kumar, Susanne Hartz

RMD Open· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain.
Erin Johansson, Mercedes Nuñez, Axel Svedbom, Tatiana Dilla, Susanne Hartz

Clinicoecon Outcomes Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of sequential biologic therapy with ixekizumab versus secukinumab as first-line treatment of moderate-to-severe psoriasis in the UK.
Erin Colleen Johansson, Susanne Hartz, Sandeep Himatlal Kiri, Gayathri Kumar, Axel Svedbom

J Med Econ· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis.
Sarah Al Sawah, Shonda A Foster, Russel Burge, David Amato, Alexander Schacht, Susanne Hartz

J Med Econ· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
A Simon Pickard, Melinda Gooderham, Susanne Hartz, Claudia Nicolay

J Med Econ· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation.
Susanne Hartz, Denis Getsios, Sunning Tao, Steve Blume, Grant Maclaine

BMC Neurol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health policy decisions on medical innovations: what role can early economic evaluation play?
Susanne Hartz, Jürgen John

Health Policy· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of economic evaluation to decision making in early phases of product development: a methodological and empirical review.
Susanne Hartz, Jürgen John

Int J Technol Assess Health Care· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine.
Wolf H Rogowski, Susanne C Hartz, Jürgen H John

BMC Health Serv Res· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis